David P. Perry - Dec 18, 2023 Form 4 Insider Report for Better Therapeutics, Inc. (BTTX)

Signature
/s/ Leslie Miller, Attorney-in-fact
Stock symbol
BTTX
Transactions as of
Dec 18, 2023
Transactions value $
$0
Form type
4
Date filed
12/20/2023, 05:24 PM
Previous filing
Jul 31, 2023
Next filing
Jan 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BTTX Common Stock Award $0 +3.75K +3.69% $0.00 105K Dec 18, 2023 Direct
holding BTTX Common Stock 13M Dec 18, 2023 By Perry Trust F1
holding BTTX Common Stock 3.64M Dec 18, 2023 By Maule-fFinch Trust F2
holding BTTX Common Stock 293K Dec 18, 2023 By spouse F3
holding BTTX Common Stock 21.3K Dec 18, 2023 By Pensus Limited Trust F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are owned directly by the Perry Trust, a ten percent owner of the Issuer, and indirectly by David P. Perry ("Perry") as trustee of the Perry Trust. Perry is an officer, director and ten percent owner of the Issuer.
F2 These shares are owned directly by the Georgianna Maule-Ffinch 2015 Trust (the "Maule-Ffinch Trust"), a ten percent owner of the Issuer and indirectly by Perry's spouse, Georgianna Maule-Ffinch ("Maule-Ffinch"), as the sole trustee of the Maule-Ffinch Trust, for the benefit of Maule-Ffinch and her children. Perry disclaims beneficial ownership of these securities, and the filing of this Form 4 is not an admission that Perry is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F3 These shares are owned direclty by Maule-Ffinch.
F4 These shares are owned directly by Doland R. Leo, Trustee of Pensus Limited Trust dated 06/12/2010 FBO Georgianna Maule-Ffinch (the "Pensus Limited Trust") for the benefit of Maule-Ffinch. Perry disclaims beneficial ownership of these securities, and the filing of this Form 4 is not an admission that Perry is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.